EHRA opposes timeframe of 2015 certification criteria

The Electronic Health Record Association (EHRA) raised concerns about a proposed rule containing voluntary certification criteria for EHR systems in 2015, according to a letter sent to the Office of the National Coordinator for Health IT (ONC).

The certification criteria propose developing a way for non-Meaningful Use EHR systems to become certified; enhancing interoperability efforts; issuing new certification criteria on functionality for patient population filtering of clinical quality measures; and improving alignment with other HHS programs and recommendations from the Office of Inspector General.

The proposed rule would allow ONC to more frequently update certification criteria to reflect new standards and to offer regulatory clarity.

In the letter, EHRA responded specifically to two parts of the proposed rule--frequency of certification and risks associated with enhanced clinical quality measures.

"Knowing that final specifications, test scripts and tools likely will not be available until months after the final rule comes out, we and our customers actually have even less time for all this work," the letter reads. In addition, the group called the 2015 edition implementation schedule an "unrealistic timeframe."

EHRA proposed re-naming the current certification criteria the "2016 Edition ... to provide some semblance of reality in terms of expectations by other federal agencies and EHR users as to when some of the final proposed functionality might be implemented."

"More frequent certification is not desirable and would be costly," the association notes.

EHRA also asked ONC "to consider a more incremental approach to the eventual implementation and adoption of these standards, ensuring that each one has been fully tested and piloted prior to requiring adoption by all EHRs."

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.